Overview of Biomarkers in Alzheimer's Disease
Author Information
Author(s): Wattamwar Pandurang R, Mathuranath P. S.
Primary Institution: Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)
Hypothesis
The study aims to identify and discuss various candidate biomarkers for early diagnosis of Alzheimer's disease.
Conclusion
The quest for an ideal biomarker for Alzheimer's disease continues despite significant advances in the field.
Supporting Evidence
- Alzheimer's disease is the most common progressive neurodegenerative disease affecting the elderly.
- Biomarkers can help detect Alzheimer's disease at an early stage.
- Current diagnostic criteria fail to identify patients in the prodromal or preclinical stages.
Takeaway
Scientists are looking for special markers that can help find Alzheimer's disease early, even before symptoms show up.
Methodology
The review discusses various candidate biomarkers in five spheres: biochemical, neuroanatomical, metabolic, genetic, and neuropsychological.
Limitations
The lack of complete understanding of the underlying pathogenic process and the unavailability of histopathological diagnosis during life are major barriers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website